FDA NDC Directory · JSON-LD · Markdown

Apidra

NDC 0088-2500 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin glulisine
Labeler / Manufacturersanofi-aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA021629
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsINSULIN GLULISINE (100 [iU]/mL)
Marketing started20090224
Package count2

External sources

Source: openFDA. Public-domain (CC0).